NASDAQ:NDRA - US29273B5003 - Common Stock
The current stock price of NDRA is 4.39 USD. In the past month the price decreased by -14.42%. In the past year, price decreased by -56.45%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 26.98 | 230.05B | ||
BSX | BOSTON SCIENTIFIC CORP | 38 | 159.33B | ||
ISRG | INTUITIVE SURGICAL INC | 54.8 | 158.15B | ||
SYK | STRYKER CORP | 30.24 | 148.55B | ||
MDT | MEDTRONIC PLC | 16.68 | 118.33B | ||
BDX | BECTON DICKINSON AND CO | 13.29 | 54.35B | ||
IDXX | IDEXX LABORATORIES INC | 52.79 | 50.72B | ||
EW | EDWARDS LIFESCIENCES CORP | 31.6 | 47.68B | ||
RMD | RESMED INC | 28.19 | 39.42B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.53 | 33.05B | ||
DXCM | DEXCOM INC | 46.42 | 30.95B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 16.16 | 26.14B |
ENDRA Life Sciences, Inc. develops medical imaging technology. The company is headquartered in Ann Arbor, Michigan and currently employs 21 full-time employees. The company went IPO on 2017-06-28. TAEUS is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical diagnostic tools. TAEUS technology uses a pulsed energy source, specifically, radio frequency (RF), to transmit energy deep into tissue and generate ultrasonic waves based on the tissue composition (or tissue chemistry), differentiating lean and fatty tissues. These waves are then detected with ultrasound sensors at the skin surface and used to create high-contrast images using its proprietary algorithms.
ENDRA LIFE SCIENCES INC
3600 Green Ct Ste 350
Ann Arbor MICHIGAN 48105 US
CEO: Francois Michelon
Employees: 21
Phone: 17343350468
The current stock price of NDRA is 4.39 USD. The price increased by 2.57% in the last trading session.
The exchange symbol of ENDRA LIFE SCIENCES INC is NDRA and it is listed on the Nasdaq exchange.
NDRA stock is listed on the Nasdaq exchange.
7 analysts have analysed NDRA and the average price target is 46.92 USD. This implies a price increase of 968.79% is expected in the next year compared to the current price of 4.39. Check the ENDRA LIFE SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ENDRA LIFE SCIENCES INC (NDRA) has a market capitalization of 3.29M USD. This makes NDRA a Nano Cap stock.
ENDRA LIFE SCIENCES INC (NDRA) currently has 21 employees.
ENDRA LIFE SCIENCES INC (NDRA) has a support level at 4.08 and a resistance level at 4.87. Check the full technical report for a detailed analysis of NDRA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NDRA does not pay a dividend.
ENDRA LIFE SCIENCES INC (NDRA) will report earnings on 2025-11-13.
ENDRA LIFE SCIENCES INC (NDRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-20.8).
The outstanding short interest for ENDRA LIFE SCIENCES INC (NDRA) is 17.31% of its float. Check the ownership tab for more information on the NDRA short interest.
ChartMill assigns a technical rating of 1 / 10 to NDRA. When comparing the yearly performance of all stocks, NDRA is a bad performer in the overall market: 85.73% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to NDRA. NDRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months NDRA reported a non-GAAP Earnings per Share(EPS) of -20.8. The EPS increased by 96.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -312.19% | ||
ROE | -594.98% | ||
Debt/Equity | 0 |
7 analysts have analysed NDRA and the average price target is 46.92 USD. This implies a price increase of 968.79% is expected in the next year compared to the current price of 4.39.